Enumeral Biomedical uses a nanotechnology-enabled process for therapeutic discovery, immune profiling and personalized medicine.
Industries BiotechnologyNanotechnologyPrecision MedicineTherapeuticsHeadquarters Regions Greater New York Area, East Coast, Northeastern US Closed Date Feb 7, 2018 Founded Date 2009 Founders Arthur H. Tinkelenberg, John J. Rydzewski Operating Status Closed Last Funding Type Post-IPO Debt Legal Name Enumeral Biomedical Holdings, Inc.
Stock Symbol OTCQB:ENUM Company Type For Profit
Contact Email info@enumeral.com Phone Number 2127523633
Enumeral Biomedical uses its microengraving (nanotechnology-enabled) process to address opportunities in immunology including therapeutic discovery, immune profiling and personalized medicine.